Local modifications in tissular conditions before PFA increases acute lesion size
Year: 2025
Type: article
Abstract: Pulsed field ablation (PFA) is a novel nonthermal cardiac ablation technology based on irreversible electroporation. Although calcium-enhanced electroporation to treat solid tumors has proved successful, the applicability of this technique to create deeper lesions in the left ventricle remains unknown. This study aimed to determine whether changes in local tissular conditions may have an impact on lesion formation in PFA. 5 anesthetized pigs received local epicardial injections of 200 mM calcium chloride (CaCl 2 ) and PFA treatments. Local injections of phosphate-buffered saline (buffer) solution combined with PFA treatments and local injections of CaCl 2 without PFA treatments were also performed. Acute lesion formation was assessed after 2 hours by 2,3,5-triphenyltetrazolium chloride staining. We performed 31 ablations (21 CaCl 2 + PFA, 10 buffer + PFA, 3 CaCl 2 alone). Histological staining of acute lesions revealed that the CaCl 2 + PFA lesions were larger than buffer + PFA lesions (width CaCl 2 + PFA vs buffer + PFA 5.9 ± 0.9 mm vs 4.3 ± 0.9 mm; P < .01). Injection of CaCl 2 alone did not produce any observable lesion. In 48% of CaCl 2 + PFA lesions, ventricular fibrillation was induced compared with 0% in buffer + PFA lesions. In this proof-of-concept study, we show for the first time that changes in local tissular conditions may have an impact on lesion formation in PFA. The combination of calcium injection and PFA induced ventricular fibrillation in half of the applications.
Source: Heart Rhythm O2
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,150
Funders: Fundació la Marató de TV3, Ministerio de Ciencia, Innovación y Universidades, European Commission, Generalitat de Catalunya, Institució Catalana de Recerca i Estudis Avançats, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Horizon 2020 Framework Programme, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación, H2020 European Research Council, H2020 Marie Skłodowska-Curie Actions
Awards: G2900949925, Desarrollo traslacional de un nuevo sistema de ablación de arritmias por catéter monopolar basado en la Electroporación Irreversible, G6866485146, G710284852, G7759132266, Un nuevo sistema de impedancia miocárdica multifrecuencia para caracterizar y monitorizar las lesiones por ablación por radiofrecuencia en miocardio sano y cicatricial, G8987752416
OpenAlex ID: W4416844823
